Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Combination treatment with Abbott PARP inhibitor and doxorubicin increases life span

Oct. 6, 2004

Selective topoisomerase I poison for cancer therapy

Oct. 6, 2004

A PABA combination regimen shows promise in refractory melanoma

Oct. 5, 2004

RTA-203: a new mammalian V-ATPase inhibitor in preclinical testing

Oct. 5, 2004

Tarceva NDA accepted for priority review

Oct. 5, 2004

AP-23573 enters phase II study for bone and soft tissue sarcomas

Oct. 5, 2004

Multiple targets elucidated for anti-GI cancer agent HKH-40A

Oct. 5, 2004

Santaris describes novel potent Bcl-2 inhibitor SPC-2004

Oct. 5, 2004

ANG-704: A metabolically stable bioreductive prodrug of combretastatin A4

Oct. 5, 2004

French team identifies new G-quadruplex-binding telomerase inhibitors

Oct. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...